Immunogenicity, Safety and Consistency Of New Trivalent Inactivated Influenza Vaccine

To augment the available influenza vaccine supply, a phase III study was conducted to evaluate the immunogenicity, safety, and consistency of a new trivalent inactivated influenza vaccine manufactured by CSL Limited. Healthy adults (ages 18–64) were randomized to receive either a single dose of TIV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Talbot, H. Keipp, Keitel, Wendy, Cate, Thomas R., Treanor, John, Campbell, James, Brady, Rebecca C., Graham, Irene, Dekker, Cornelia L., Ho, Dora, Winokur, Patricia, Walter, Emmanuel, Bennet, Jillian, Formica, Neil, Hartel, Gunter, Skeljo, Maryanne, Edwards, Kathryn M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2605420/
https://ncbi.nlm.nih.gov/pubmed/18602726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.05.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados